D

Duopharma Biotech Bhd
KLSE:DPHARMA

Watchlist Manager
Duopharma Biotech Bhd
KLSE:DPHARMA
Watchlist
Price: 1.23 MYR Market Closed
Market Cap: 1.2B MYR
Have any thoughts about
Duopharma Biotech Bhd?
Write Note

Income Statement

Earnings Waterfall
Duopharma Biotech Bhd

Revenue
748m MYR
Cost of Revenue
-478.8m MYR
Gross Profit
269.2m MYR
Operating Expenses
-188.7m MYR
Operating Income
80.5m MYR
Other Expenses
-31m MYR
Net Income
49.5m MYR

Income Statement
Duopharma Biotech Bhd

Rotate your device to view
Income Statement
Currency: MYR
Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024
Revenue
Revenue
168
N/A
172
+2%
177
+3%
182
+3%
198
+9%
232
+18%
270
+16%
304
+13%
327
+8%
327
+0%
313
-4%
354
+13%
392
+11%
427
+9%
468
+9%
478
+2%
485
+1%
495
+2%
499
+1%
516
+3%
537
+4%
554
+3%
576
+4%
585
+1%
583
0%
574
-2%
570
-1%
578
+1%
590
+2%
628
+6%
639
+2%
659
+3%
685
+4%
690
+1%
697
+1%
711
+2%
697
-2%
689
-1%
705
+2%
697
-1%
748
+7%
Gross Profit
Cost of Revenue
(96)
(96)
(95)
(97)
(106)
(121)
(141)
(162)
(173)
(179)
(169)
(204)
(228)
(249)
(281)
(283)
(287)
(299)
(294)
(305)
(316)
(325)
(344)
(345)
(349)
(345)
(337)
(343)
(351)
(375)
(385)
(397)
(415)
(415)
(417)
(425)
(414)
(414)
(436)
(437)
(479)
Gross Profit
71
N/A
76
+6%
82
+8%
85
+4%
92
+8%
112
+22%
129
+15%
142
+10%
153
+8%
149
-3%
144
-3%
150
+4%
164
+9%
179
+9%
187
+4%
195
+4%
198
+1%
196
-1%
204
+4%
211
+3%
221
+5%
230
+4%
232
+1%
240
+3%
233
-3%
228
-2%
233
+2%
234
+0%
239
+2%
253
+6%
254
+0%
262
+3%
271
+3%
276
+2%
280
+2%
286
+2%
283
-1%
276
-3%
268
-3%
260
-3%
269
+3%
Operating Income
Operating Expenses
(32)
(34)
(35)
(38)
(46)
(64)
(79)
(93)
(106)
(106)
(111)
(116)
(124)
(132)
(133)
(139)
(141)
(137)
(139)
(138)
(141)
(147)
(155)
(165)
(158)
(154)
(151)
(147)
(151)
(160)
(165)
(170)
(177)
(182)
(187)
(191)
(191)
(191)
(190)
(186)
(189)
Selling, General & Administrative
(31)
(33)
(33)
(33)
(41)
(60)
(78)
(96)
(108)
(108)
(109)
(114)
(122)
(128)
(129)
(135)
(137)
(133)
(138)
(139)
(141)
(147)
(155)
(160)
(155)
(154)
(150)
(149)
(154)
(162)
(166)
(171)
(176)
(180)
(186)
(190)
(190)
(189)
(187)
(179)
(182)
Other Operating Expenses
(0)
(1)
(2)
(5)
(5)
(4)
(1)
2
2
2
(2)
(2)
(3)
(4)
(4)
(4)
(4)
(4)
(1)
1
0
0
1
(6)
(3)
(0)
(1)
2
3
1
1
1
(1)
(2)
(1)
(1)
(1)
(2)
(3)
(7)
(7)
Operating Income
40
N/A
42
+6%
47
+12%
48
+2%
46
-4%
48
+3%
50
+5%
48
-4%
48
-1%
42
-11%
33
-22%
34
+5%
40
+15%
47
+19%
54
+16%
56
+3%
57
+2%
59
+4%
65
+10%
72
+11%
80
+10%
83
+4%
77
-7%
75
-2%
75
0%
75
-1%
82
+9%
87
+7%
88
+1%
92
+5%
89
-4%
92
+4%
93
+1%
94
+1%
93
-1%
95
+3%
92
-3%
84
-9%
79
-7%
74
-6%
80
+9%
Pre-Tax Income
Interest Income Expense
(0)
(0)
(0)
(0)
(0)
(2)
(2)
(3)
(3)
(2)
(1)
(2)
(2)
(3)
(2)
(3)
(4)
(5)
(5)
(7)
(9)
(8)
(6)
(6)
(4)
(5)
(5)
(6)
(6)
(6)
(5)
(6)
(6)
(7)
(8)
(9)
(11)
(13)
(15)
(19)
(20)
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Other Income
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
(0)
0
0
0
(0)
0
0
0
(0)
0
0
0
(1)
0
0
0
(1)
0
0
0
(0)
0
0
0
(1)
0
0
Pre-Tax Income
40
N/A
42
+6%
47
+11%
48
+2%
46
-4%
46
+1%
48
+4%
46
-5%
45
-2%
41
-9%
31
-23%
33
+4%
38
+15%
44
+18%
52
+17%
53
+2%
53
+1%
55
+3%
60
+9%
65
+9%
71
+8%
75
+6%
71
-5%
70
-2%
71
+2%
70
-2%
76
+9%
82
+7%
83
+1%
86
+5%
83
-4%
86
+4%
88
+2%
87
-1%
85
-2%
87
+2%
82
-6%
72
-12%
63
-12%
55
-13%
60
+10%
Net Income
Tax Provision
(9)
(9)
(11)
(12)
(12)
(12)
(11)
(10)
(12)
(10)
(5)
(5)
(4)
(6)
(9)
(9)
(9)
(10)
(12)
(14)
(16)
(17)
(16)
(15)
(16)
(15)
(18)
(19)
(19)
(20)
(17)
(18)
(19)
(18)
(15)
(14)
(13)
(10)
(11)
(10)
(11)
Income from Continuing Operations
31
33
35
36
34
34
36
35
33
31
27
28
33
38
42
43
44
45
48
52
55
58
55
54
55
54
59
63
63
66
66
68
69
69
70
72
69
61
53
45
49
Income to Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Income (Common)
31
N/A
33
+6%
35
+8%
36
+2%
34
-5%
34
0%
36
+7%
35
-3%
33
-5%
31
-7%
27
-13%
28
+3%
33
+21%
38
+15%
42
+11%
43
+2%
44
+2%
45
+3%
48
+5%
52
+8%
55
+7%
58
+5%
55
-4%
54
-2%
55
+1%
54
-1%
59
+8%
63
+7%
63
+1%
66
+5%
66
-1%
68
+4%
69
+1%
69
-1%
70
+2%
72
+3%
69
-5%
61
-11%
53
-14%
45
-14%
49
+9%
EPS (Diluted)
0.07
N/A
0.05
-29%
0.08
+60%
0.05
-38%
0.04
-20%
0.04
N/A
0.08
+100%
0.04
-50%
0.03
-25%
0.03
N/A
0.02
-33%
0.03
+50%
0.04
+33%
0.04
N/A
0.04
N/A
0.04
N/A
0.04
N/A
0.04
N/A
0.04
N/A
0.04
N/A
0.04
N/A
0.04
N/A
0.05
+25%
0.04
-20%
0.04
N/A
0.04
N/A
0.05
+25%
0.05
N/A
0.05
N/A
0.06
+20%
0.07
+17%
0.07
N/A
0.08
+14%
0.08
N/A
0.07
-13%
0.08
+14%
0.07
-13%
0.06
-14%
0.05
-17%
0.04
-20%
0.05
+25%

See Also

Discover More